Curative and Vytalize Expand Value-Based Care Access
Austin, Texas and Hoboken, New Jersey, August 17, 2026 Curative and Vytalize Health have finalized a major network agreement...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Austin, Texas and Hoboken, New Jersey, August 17, 2026 Curative and Vytalize Health have finalized a major network agreement...
Abbott Park, Illinois and Bethesda, Maryland, August 17, 2026 Abbott and the National Association of Community Health Centers (NACHC)...
MENLO PARK, Calif., July 31, 2026 Hippocratic AI has launched a new suite of Rapid Response Climate Agents, enabling...
FREMONT, California, USA, June 2, 2026 Alamar Biosciences has unveiled its NULISAâ„¢ Dried Blood Spot (DBS) Extraction Kit, a...
